Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'.
Director of Epidemiology, RTI Health Solutions, Waltham, MA, USA; llanza@rti.org.
Lee L
LL
Lanza
Lisa J
LJ
McQuay
Kenneth J
KJ
Rothman
Henry G
HG
Bone
Andrew M
AM
Kaunitz
Zeev
Z
Harel
Quazi
Q
Ataher
Douglas
D
Ross
Philip L
PL
Arena
Kevin D
KD
Wolter
D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans; D015994:Incidence; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Bone Fracture; DMPA